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Background: Some patients with Prader-Willi Syndrome (PWS) have symptoms of constipation, but bowel function
in PWS has never been systematically evaluated. The aim of the present study was to describe colorectal function
in PWS by means of validated techniques.
Methods: Twenty-one patients with PWS (14 women, age 17–47 (median = 32)) were evaluated with the Rome III
constipation criteria, stool diary, digital rectal examination, rectal diameter assessed from transabdominal ultrasound,
and total gastrointestinal transit time (GITT) determined with radio-opaque markers. Results were compared with
those of healthy controls.
Results: Among PWS patients able to provide information for Rome III criteria, 8/20 (40%) fulfilled the criteria for
constipation. Most commonly reported symptoms were a feeling of obstructed defecation (8/19, 42%), <3
defecations per week (8/17, 47%), straining during defecation (7/19, 37%) and lumpy or hard stools (6/19, 32%).
Rectal diameter did not differ between PWS (median 3.56 centimeters, range 2.24–5.36) and healthy controls
(median 3.42 centimeters, range 2.67–4.72) (p = 0.96), but more PWS patients (13/20; 65%) than healthy controls
(3/25; 12%) (p < 0.001) had fecal mass in the rectum. Median GITT was 2.0 days (range 0.5–4.4) in PWS versus 1.6
(range 0.7–2.5) in the control group (p = 0.26). However, GITT was >3 days in 5/21 (24%) of PWS and none of the
controls (p = 0.047).
Conclusion: Constipation is very common in PWS. Patients with PWS have an increased prevalence of prolonged
GITT and palpable stools in the rectum at digital rectal examination.
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UltrasonographyBackground
Prader-Willi Syndrome (PWS) is a multisystemic genetic
disease which was first described in 1956 [1]. The inci-
dence of PWS is 1:15.000–30.000 newborns [2]. The
syndrome is characterized by muscular hypotonia, feeding
difficulties and failure to thrive in the early childhood [3].
Further characteristics are developmental delay, short stature
and hypogonadism [2]. During childhood a certain de-
meanor characterized by a food-seeking behavior and hyper-
phagia develops. Patients may also develop compulsive-like* Correspondence: stenfarh@rm.dk
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distribution, and reproduction in any mediumbehavior with skin and rectal picking. In severe cases the lat-
ter can lead to rectal prolapse and fecal incontinence [3].
Gastrointestinal function in PWS is sparsely investi-
gated. Three studies have found either normal [4,5] or
slow gastric emptying in PWS [6]. Also, serious events
with gastric rupture and necrosis and other gastrointes-
tinal problems have been reported [7-9]. Other studies
have found an increased prevalence of constipation in
mentally disabled patients [10-12]. In spite of this, colo-
rectal function, including constipation, has never been
systematically evaluated in PWS.
Constipation is normally a symptom based diagnosis.
Since 2006, the Rome III criteria have gained general ac-
ceptance for defining constipation in a clinical settingtral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
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or more abdominal x-rays is a simple and commonly used
method for assessment of total gastrointestinal transit
time (GITT) [13]. As transit time through the colorectum
is much longer than gastric emptying or small intestinal
transit time, GITT mainly reflects colorectal transit time
and both terms are often used. Some patients have normal
or almost normal GITT but still suffer from severe symp-
toms of constipation. This is often caused by disordered
rectal evacuation and estimation of rectal diameter by
transabdominal ultrasonography (US) has been intro-
duced for non-invasive and risk free evaluation of rectal
impaction in children [14-17].
Based on clinical experience, we hypothesized that cons-
tipation is common in PWS. Accordingly, the aim of the
present study was to describe symptoms of constipation
in a group of adult patient with PWS and to compare
commonly used parameters of colorectal function in pa-
tients with PWS and healthy controls.
Methods
The study was performed in accordance with the Helsinki
II declaration and approved by the Central Denmark
Region Committees on Health Research Ethics (registra-
tion number 20110043) and the Danish Data Protection
Agency.
Among 28 PWS patients consecutively seen at the
outpatient clinic at Centre for Rare Diseases, Aarhus
University Hospital, 21 (14 women, age 17-47 years
(median 32)) with a BMI of 23.6 (18.1–43.0) were in-
cluded in the present study. Eight patients were obese
as defined by a BMI > 25. All patients, their GP and
their guardian gave written consent to participate in
the study. Seven were excluded because of previous
major abdominal surgery (n = 1), treatment with medi-
cations affecting gastrointestinal motility (n = 3), failed
genetic diagnosis (n = 1), or inability to follow the study
protocol (n = 2). In 19 patients PWS was caused by a dele-
tion and in two uniparental disomy. Patients were evalu-
ated with the Rome III constipation criteria and they were
helped to complete a two-week stool diary. A clinical
examination including digital rectal examination and US
were performed in each subject. Finally, GITT was deter-
mined with radio-opaque markers as described below.
For comparison of rectal diameter determined with US,
we recruited 30 healthy volunteers (16 women, aged
20-67 years (median = 26)) with a BMI of 23.1 (17.7–30.0)
without previous major gastrointestinal surgery and with-
out medication or present disease affecting gastrointestinal
function. None of the healthy controls were constipated
according to the Rome III constipation criteria.
The control subjects were scanned by 3 doctors, in-
cluding one experienced radiologist, and no significant
inter- or intra-observer variability were found.For ethical reasons and to reduce exposure of healthy
subjects to irradiation, GITT in PWS patients were com-
pared to existing normative data from our unit (16
healthy adults, 12 men, aged 23-60 years (median 31)).
Rome III constipation criteria
The Rome III criteria cover various symptoms of consti-
pation [13]. The patients completed a questionnaire in
plain language covering Rome III criteria together with a
parent or a care assistant from their group homes. The
helpers could thereby clarify the meaning of the ques-
tions, if the patients had trouble understanding them.
Stool diary
For a period of 14 days the patients were helped to register
every defecation, passing of water and episode of fecal and
urinary incontinence by marking in a date and time table
divided into columns headed by correlating drawings of a
toilet, stools, urine and underpants, respectively. Data of
stool consistency was not obtained in purpose of minimiz-
ing the risk of provoking their food-seeking behavior to-
wards their stools.
Clinical examination
The clinical examination included perianal inspection
and digital rectal examination. We examined the po-
sition of anus, presence of perianal feces, reddening,
eczema, fissures, haemorrhoids, perianal sensibility,
anal sphincter tone, voluntarily contraction/relaxation
of the anal sphincter and the amount and consistency
of feces in the rectum.
Gastrointestinal transit time
Assessment of GITT was performed according to
Abrahamsson et al. etc. [13,15,17,18]. Subjects took
six gelatine capsules each containing 10 radio-opaque
markers each morning for six consecutive days. On
the seventh day an X-ray of the abdomen was taken
and the number of radio markers was counted. From
this the GITT in days was calculated as:
GITTd ¼ M þ fxDð Þ
D
where f is the fraction of the daily dose chosen for esti-
mation of GITT. We have chosen to set f to 0.5 as in
earlier studies [17,19]. D is the number of radio-opaque
markers per day, in our case 10, and M is the amount of
remaining markers on the X-ray.
The segmental colonic transit time (SCTT) of the right
(caecum, ascending and transverse colon) and the left
colorectum (descending colon and rectosigmoid) were
calculated as [20,21]:
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Ultrasonic measurement of rectal diameter
With subjects in the supine position the scanner (MINDRAY
M5 Portable Ultrasound Scanner, Mindray, Shenzhen,
China) with an abdominal curved 5 MHz probe was
placed a few centimeters above the symphysis and the
probe was angled 20 degrees towards os sacrum. Con-
firming that the bladder was not empty and, thereby,
having acceptable conditions for imaging, the rectal
diameter was measured as the transverse distance (right
to left) of the outer rectal contour and by carefully identi-
fying its widest part. The interface between the hypoe-
choic muscular wall and the hyperechoic perirectal fat was
used. This was done three times and the mean value was
calculated. After US perianal inspection and digital rectal
examination were performed and it was noted whether
palpable stools was present.
Statistical analysis
The Mann-Whitney U-test was used for comparison of
groups. The proportion of subjects with GITT > 3 day
was compared by the Fishers exact test. Correlation was
tested by the Pearson test of linear correlation. P < 0.05
was considered statistically significant. The statistical
calculations were performed with R 2.14.1 software
(R Foundation, Vienna, Austria).
Results
Twenty of 21 PWS patients provided reliable informa-
tion about the Rome III criteria and among these, eight
(40%) fulfilled the definition of constipation. Even though
the group of PWS patients had a median number of bowel
movements per day of 1.6 (range 1–3.8), specific constipa-
tion related symptoms were frequent (Table 1). In total,
only two episodes of urinary incontinence and one episode
of fecal incontinence were reported during a two-week
period.Table 1 The Rome III constipation criteria
Criteria (at least 25 % of defecations) Frequency of
symptom
Straining during defecation 7/19 (37%)
Lumpy or hard stools 6/19 (32%)
Sensation of incomplete evacuation 3/20 (15%)
Sensation of anorectal obstruction/blockage 8/19 (42%)
Manual manoeuvres to facilitate defecation 0/20 (0%)
Fewer than 3 defecations per week 8/17 (47%)
Loose stools are rarely present without laxatives 3/20 (15%)
Insufficient criteria for IBS (irritable
bowel syndrome)
20/20 (100%)Rectal diameter did not differ between PWS (median
3.56 centimeters, range 2.24–5.36) and healthy volun-
teers (median 3.42 centimeters, range 2.67-4.72) (p =
0.96) (Figure 1). However, more PWS patients (13/20;
65%) than healthy volunteers (3/30; 10%) (p < 0.001) had
fecal mass in the rectum at digital examination. No fis-
sures, eczema, haemorrhoides or rectal bleeding were
observed neither in the PWS nor in the control group.
Likewise the perianal sensibility and anal sphincter tone
were normal in both groups.
Median GITT was 2.0 days (range 0.5–4.4) in PWS ver-
sus 1.6 (range 0.7–2.5) in the control group (p = 0.26).
However, GITT was >3 days in 5/21 (24%) of PWS and
none of the controls (p = 0.047) (Figure 2). Median transit
time of the right colon was 0.6 days (range 0-2.2)
compared to 0.4 days (range 0–1) in healthy volunteers
(p = 0.32). Median transit time of the left colorectum
was 0.9 days (range 0-2.6) in PWS patients and 0.6 days
range (0.2–1.2) in controls (p = 0.48).
There was a trend towards a correlation between Rome
III evaluation and presence of feces in the rectum (p =
0.09, r = 0.38) but not between Rome III and GITT (p =
0.39, r = 0.20). Likewise, there was no correlation between
rectal diameter and presence of feces in the rectum (p =
0.83, r = -0.3). There was no difference between male and
female PWS patients in terms of GITT (p = 0.75), rectal
diameter (p = 0.58) and number of Rome III criteria met
(p = 0.74). Furthermore, we did not find any correlation
213 between BMI and signs of constipation (palpable
stools 214 in the rectum (p = 0.47) and GITT (p = 0.34)).
Discussion
The main finding of the present study was that adult
patients with PWS had a surprisingly high prevalence
of constipation related symptoms compared to that
reported in the general population [21]. Congruently,
significantly more PWS patients than healthy controls
had prolonged GITT and stools in the rectum. The
study design was descriptive and does not allow any
conclusions about the pathophysiology of constipation
in PWS.
Patients with PWS have abnormal eating habits. How-
ever, all patients but two in the present study lived at in-
stitutions with daily routines specially adapted to PWS,
including a fixed healthy diet. Therefore, diet cannot ex-
plain our results. Recollection bias may be a problem,
especially in persons with intellectual deficits, and stool
diaries may have been incomplete in spite of help from
caretakers. However, the objective methods used sup-
ported the symptom based data.
Symptoms of constipation are common and 11% of
the general population fulfills the Rome III criteria [21].
This is, however, still much less than the 40% observed









Figure 1 Rectal diameters in adults with Prader-Willi Syndrome (black) and healthy adult controls (grey).
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scribed in a recent paper [22]. Objectified with radio-
graphic colonic transit time, the prevalence of slow
colonic transit is 2-4% in the general population, when
slow transit constipation is defined as a GITT above 3 days
[23,24]. This is in contrast to the 24% prevalence observed
among PWS patients in the present study.
We can only speculate about the pathophysiology be-
hind constipation in PWS. The presence of stools in the











Figure 2 Total gastrointestinal transit times in days in adults with Prawas, however, not supported by the SCTT, where pro-
longed transit of the left colon should be expected in
case of a severe evacuation disorder. Normal defecation
is preceded by colonic mass movement and sensation of
stool in the rectum. Abnormal rectal sensation would be
coherent with the typical PWS characteristic of abnor-
mal conception of physiological signals from the body
[2,3,9]. Patients with PWS usually have reduced tone of
striated muscles. Reduced tone of the smooth muscle
cells within the colorectum may lead to constipation2-3 >3
T (days)
der-Willi Syndrome (black) and healthy adult controls (grey).
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including evaluation of rectal sensation and biomechan-
ics are needed to clarify this.
In various patient groups, including irritable bowel syn-
drome and connective tissue disorders, constipation is
part of general gastrointestinal dysmotility [18,19]. It is
unknown whether this is the case in PWS too. Further-
more it is debatable whether gastric emptying is prolonged
[6] or not [4,5] and small intestinal transit has not been
evaluated. Gold standard for evaluation of small intestinal
transit is scintigraphy which is not widely available and ex-
poses the subject to irradiation. New and minor invasive
methods suitable for studying small intestinal transit in
PWS include the Wireless Motility Capsule [25] and the
magnet based Motility Tracking System [26].
Ghrelin is an orexigenic hormone and the amount of
ghrelin in gastric tissue [27] as well as in plasma [28] is
higher than normal in PWS. Ghrelin has a prokinitic ef-
fect stimulating gastrointestinal motility. Thus abnormal
gastrointestinal function in PWS must be caused by an-
other mechanism [4].
Assessment of rectal diameter by a transabdominal US
is sensitive for diagnosing rectal impaction in children
[14]. We established a normal adult material and we
confirmed that intra- and inter-observer validity were
good (unpublished data) before investigating the PWS
patients. In both groups there was no correlation be-
tween rectal diameter and presence of stools in the rec-
tum. Further studies are, however, needed before
introducing US in clinical evaluation of constipation in
adults.
Gastrointestinal symptoms including constipation are
more common in obese children compared to normal-
weight children [29,30]. However, a correlation between
obesity expressed as high BMI and constipation in adults
is more controversial and most studies cannot confirm
this association [23,31].Conclusion
We found that 40% of adult PWS patients have consti-
pation according to the Rome III criteria which is con-
siderably more than reported in the general population.
Also, PWS patients have an increased prevalence of
palpable stools in the rectum and a prolonged GITT.
Given that PWS patients often lack the ability to inter-
pret body signals as well as expressing symptoms it is
necessary for parents, caretakers and clinicians to pay
special attention to bowel related symptoms. Based on
our findings, a thorough clinical history combined with
a physical examination including rectal digital examin-
ation is sufficient to diagnose constipation in PWS. In
addition, GITT can be considered. Abdominal US does
not provide any additional information.Competing interests
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